Natasha Iliskovic
- Cardiology and Cardiovascular Medicine top 1%
- Oncology top 5%
- Molecular Biology top 10%
- Biophysics top 1%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Pawan K. SingalTimao LiDinender KumarIgor DanelisenNeelam KhaperSiraj WaliVince PalaceGrant N. Pierce
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (8 papers)Cardiovascular Function and Risk Factors (5 papers)Cancer Treatment and Pharmacology (3 papers)
In The Last Decade
Natasha Iliskovic
11 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cardiology and Cardiovascular Medicine 1.6k
- Oncology 717
- Molecular Biology 706
- Biophysics 314
- Pathology and Forensic Medicine 298
Countries citing papers authored by Natasha Iliskovic
This map shows the geographic impact of Natasha Iliskovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natasha Iliskovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natasha Iliskovic more than expected).
Fields of papers citing papers by Natasha Iliskovic
This network shows the impact of papers produced by Natasha Iliskovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natasha Iliskovic. The network helps show where Natasha Iliskovic may publish in the future.
Co-authorship network of co-authors of Natasha Iliskovic
This figure shows the co-authorship network connecting the top 25 collaborators of Natasha Iliskovic. A scholar is included among the top collaborators of Natasha Iliskovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natasha Iliskovic. Natasha Iliskovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 362 | |
| 2 | 24 | |
| 3 | 28 | |
| 4 | Doxorubicin-Induced Cardiomyopathybreakdown → | 1511 |
| 5 | 25 | |
| 6 | 23 | |
| 7 | Susceptibility of LDL to oxidative stress in obstructive sleep apnea. | 72 |
| 8 | 255 | |
| 9 | 3 | |
| 10 | Lipid lowering: an important factor in preventing adriamycin-induced heart failure. | 104 |
| 11 | 5 |
About Natasha Iliskovic
Natasha Iliskovic is a scholar working on Biophysics, Cardiology and Cardiovascular Medicine and Oncology, having authored 11 papers that have together received 2.4k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Cardiovascular Function and Risk Factors (5 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.6k citations), Biophysics (314 citations) and Oncology (717 citations). Natasha Iliskovic has collaborated with scholars based in Canada and Slovakia. Frequent co-authors include Pawan K. Singal, Timao Li, Dinender Kumar, Igor Danelisen, Neelam Khaper, Siraj Wali, Vince Palace, Grant N. Pierce, Hamid Massaeli and Meir H. Kryger. Their work appears in journals such as New England Journal of Medicine, The FASEB Journal and Molecular and Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.